nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.114	0.215	CbGbCtD
Silodosin—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0772	0.145	CbGbCtD
Silodosin—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0736	0.139	CbGbCtD
Silodosin—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0656	0.124	CbGbCtD
Silodosin—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0643	0.121	CbGbCtD
Silodosin—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0607	0.114	CbGbCtD
Silodosin—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0385	0.0726	CbGbCtD
Silodosin—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0364	0.0685	CbGbCtD
Silodosin—Rhinorrhoea—Montelukast—chronic obstructive pulmonary disease	0.00495	0.0158	CcSEcCtD
Silodosin—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.00427	0.0136	CcSEcCtD
Silodosin—Sinusitis—Roflumilast—chronic obstructive pulmonary disease	0.00424	0.0135	CcSEcCtD
Silodosin—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.00376	0.012	CcSEcCtD
Silodosin—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00366	0.0117	CcSEcCtD
Silodosin—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00365	0.0117	CcSEcCtD
Silodosin—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.00355	0.0113	CcSEcCtD
Silodosin—Nasal congestion—Formoterol—chronic obstructive pulmonary disease	0.00327	0.0104	CcSEcCtD
Silodosin—Nasal congestion—Arformoterol—chronic obstructive pulmonary disease	0.00327	0.0104	CcSEcCtD
Silodosin—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00312	0.00997	CcSEcCtD
Silodosin—Nasal congestion—Salbutamol—chronic obstructive pulmonary disease	0.00308	0.00985	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00298	0.00953	CcSEcCtD
Silodosin—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00282	0.00903	CcSEcCtD
Silodosin—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.0028	0.00894	CcSEcCtD
Silodosin—Sinusitis—Tiotropium—chronic obstructive pulmonary disease	0.00266	0.00851	CcSEcCtD
Silodosin—Nasopharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00266	0.0085	CcSEcCtD
Silodosin—Nasopharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00266	0.0085	CcSEcCtD
Silodosin—Nasopharyngitis—Montelukast—chronic obstructive pulmonary disease	0.00261	0.00832	CcSEcCtD
Silodosin—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00261	0.00832	CcSEcCtD
Silodosin—Nasopharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00251	0.00802	CcSEcCtD
Silodosin—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00249	0.00795	CcSEcCtD
Silodosin—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00236	0.00753	CcSEcCtD
Silodosin—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.00231	0.00739	CcSEcCtD
Silodosin—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.0023	0.00736	CcSEcCtD
Silodosin—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.0023	0.00734	CcSEcCtD
Silodosin—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00229	0.00731	CcSEcCtD
Silodosin—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00228	0.00728	CcSEcCtD
Silodosin—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.00223	0.00714	CcSEcCtD
Silodosin—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00219	0.00699	CcSEcCtD
Silodosin—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.00215	0.00687	CcSEcCtD
Silodosin—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.00215	0.00687	CcSEcCtD
Silodosin—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.00212	0.00678	CcSEcCtD
Silodosin—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00211	0.00674	CcSEcCtD
Silodosin—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.00211	0.00673	CcSEcCtD
Silodosin—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00208	0.00665	CcSEcCtD
Silodosin—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00207	0.0066	CcSEcCtD
Silodosin—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.00203	0.00649	CcSEcCtD
Silodosin—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00199	0.00636	CcSEcCtD
Silodosin—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00197	0.0063	CcSEcCtD
Silodosin—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00196	0.00627	CcSEcCtD
Silodosin—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00195	0.00623	CcSEcCtD
Silodosin—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00191	0.0061	CcSEcCtD
Silodosin—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00191	0.0061	CcSEcCtD
Silodosin—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.0019	0.00609	CcSEcCtD
Silodosin—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00189	0.00604	CcSEcCtD
Silodosin—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00188	0.00602	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00188	0.006	CcSEcCtD
Silodosin—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00187	0.00599	CcSEcCtD
Silodosin—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00187	0.00598	CcSEcCtD
Silodosin—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00186	0.00594	CcSEcCtD
Silodosin—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00186	0.00594	CcSEcCtD
Silodosin—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00185	0.00593	CcSEcCtD
Silodosin—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00185	0.00593	CcSEcCtD
Silodosin—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00185	0.0059	CcSEcCtD
Silodosin—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00182	0.00582	CcSEcCtD
Silodosin—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00182	0.0058	CcSEcCtD
Silodosin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00182	0.0058	CcSEcCtD
Silodosin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00181	0.0058	CcSEcCtD
Silodosin—Headache—Roflumilast—chronic obstructive pulmonary disease	0.0018	0.00577	CcSEcCtD
Silodosin—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.0018	0.00576	CcSEcCtD
Silodosin—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.0018	0.00576	CcSEcCtD
Silodosin—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.0018	0.00576	CcSEcCtD
Silodosin—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00179	0.00574	CcSEcCtD
Silodosin—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00178	0.00569	CcSEcCtD
Silodosin—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00178	0.00568	CcSEcCtD
Silodosin—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00177	0.00565	CcSEcCtD
Silodosin—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00177	0.00564	CcSEcCtD
Silodosin—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00176	0.00563	CcSEcCtD
Silodosin—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00176	0.00562	CcSEcCtD
Silodosin—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00176	0.00561	CcSEcCtD
Silodosin—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00175	0.0056	CcSEcCtD
Silodosin—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00174	0.00555	CcSEcCtD
Silodosin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00171	0.00547	CcSEcCtD
Silodosin—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.0017	0.00544	CcSEcCtD
Silodosin—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00164	0.00523	CcSEcCtD
Silodosin—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00158	0.00506	CcSEcCtD
Silodosin—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00158	0.00506	CcSEcCtD
Silodosin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00157	0.00502	CcSEcCtD
Silodosin—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00156	0.005	CcSEcCtD
Silodosin—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00155	0.00495	CcSEcCtD
Silodosin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00153	0.00488	CcSEcCtD
Silodosin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00152	0.00485	CcSEcCtD
Silodosin—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00152	0.00485	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00151	0.00484	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00151	0.00484	CcSEcCtD
Silodosin—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00149	0.00478	CcSEcCtD
Silodosin—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00149	0.00477	CcSEcCtD
Silodosin—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00149	0.00477	CcSEcCtD
Silodosin—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00149	0.00475	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00148	0.00474	CcSEcCtD
Silodosin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00148	0.00473	CcSEcCtD
Silodosin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00144	0.0046	CcSEcCtD
Silodosin—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00143	0.00458	CcSEcCtD
Silodosin—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00143	0.00458	CcSEcCtD
Silodosin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00143	0.00458	CcSEcCtD
Silodosin—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00143	0.00456	CcSEcCtD
Silodosin—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00143	0.00456	CcSEcCtD
Silodosin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00142	0.00454	CcSEcCtD
Silodosin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00142	0.00454	CcSEcCtD
Silodosin—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.0045	CcSEcCtD
Silodosin—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.0014	0.00449	CcSEcCtD
Silodosin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00139	0.00444	CcSEcCtD
Silodosin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00436	CcSEcCtD
Silodosin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00436	CcSEcCtD
Silodosin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00136	0.00434	CcSEcCtD
Silodosin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00136	0.00434	CcSEcCtD
Silodosin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00433	CcSEcCtD
Silodosin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.0043	CcSEcCtD
Silodosin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00134	0.00428	CcSEcCtD
Silodosin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00132	0.00422	CcSEcCtD
Silodosin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.00422	CcSEcCtD
Silodosin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00131	0.0042	CcSEcCtD
Silodosin—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.00131	0.00418	CcSEcCtD
Silodosin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.0013	0.00414	CcSEcCtD
Silodosin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00412	CcSEcCtD
Silodosin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00128	0.00409	CcSEcCtD
Silodosin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00127	0.00406	CcSEcCtD
Silodosin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00126	0.00403	CcSEcCtD
Silodosin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00126	0.00403	CcSEcCtD
Silodosin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00399	CcSEcCtD
Silodosin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00124	0.00395	CcSEcCtD
Silodosin—Purpura—Prednisone—chronic obstructive pulmonary disease	0.00121	0.00388	CcSEcCtD
Silodosin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00121	0.00387	CcSEcCtD
Silodosin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00121	0.00387	CcSEcCtD
Silodosin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.0012	0.00384	CcSEcCtD
Silodosin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.0012	0.00383	CcSEcCtD
Silodosin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00382	CcSEcCtD
Silodosin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00382	CcSEcCtD
Silodosin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00381	CcSEcCtD
Silodosin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00117	0.00374	CcSEcCtD
Silodosin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00371	CcSEcCtD
Silodosin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00371	CcSEcCtD
Silodosin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00369	CcSEcCtD
Silodosin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00369	CcSEcCtD
Silodosin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00365	CcSEcCtD
Silodosin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00365	CcSEcCtD
Silodosin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00114	0.00365	CcSEcCtD
Silodosin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00363	CcSEcCtD
Silodosin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00113	0.00363	CcSEcCtD
Silodosin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00113	0.00362	CcSEcCtD
Silodosin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00361	CcSEcCtD
Silodosin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.0035	CcSEcCtD
Silodosin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00349	CcSEcCtD
Silodosin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00108	0.00344	CcSEcCtD
Silodosin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00335	CcSEcCtD
Silodosin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00335	CcSEcCtD
Silodosin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00103	0.0033	CcSEcCtD
Silodosin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.0033	CcSEcCtD
Silodosin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00328	CcSEcCtD
Silodosin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00324	CcSEcCtD
Silodosin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.001	0.0032	CcSEcCtD
Silodosin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.001	0.0032	CcSEcCtD
Silodosin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00099	0.00316	CcSEcCtD
Silodosin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00098	0.00313	CcSEcCtD
Silodosin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000977	0.00312	CcSEcCtD
Silodosin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000967	0.00309	CcSEcCtD
Silodosin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000967	0.00309	CcSEcCtD
Silodosin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000947	0.00303	CcSEcCtD
Silodosin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000944	0.00302	CcSEcCtD
Silodosin—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000932	0.00298	CcSEcCtD
Silodosin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000922	0.00295	CcSEcCtD
Silodosin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000922	0.00295	CcSEcCtD
Silodosin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000921	0.00294	CcSEcCtD
Silodosin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000921	0.00294	CcSEcCtD
Silodosin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000916	0.00293	CcSEcCtD
Silodosin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000916	0.00293	CcSEcCtD
Silodosin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000913	0.00292	CcSEcCtD
Silodosin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000903	0.00288	CcSEcCtD
Silodosin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000902	0.00288	CcSEcCtD
Silodosin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000897	0.00287	CcSEcCtD
Silodosin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00087	0.00278	CcSEcCtD
Silodosin—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00087	0.00278	CcSEcCtD
Silodosin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00087	0.00278	CcSEcCtD
Silodosin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000868	0.00277	CcSEcCtD
Silodosin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000868	0.00277	CcSEcCtD
Silodosin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000865	0.00276	CcSEcCtD
Silodosin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000853	0.00272	CcSEcCtD
Silodosin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000851	0.00272	CcSEcCtD
Silodosin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00082	0.00262	CcSEcCtD
Silodosin—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000779	0.00249	CcSEcCtD
Silodosin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000773	0.00247	CcSEcCtD
Silodosin—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000735	0.00235	CcSEcCtD
Silodosin—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000731	0.00234	CcSEcCtD
Silodosin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000716	0.00229	CcSEcCtD
Silodosin—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000709	0.00227	CcSEcCtD
Silodosin—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000632	0.00202	CcSEcCtD
Silodosin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000629	0.00201	CcSEcCtD
Silodosin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00062	0.00198	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000596	0.0019	CcSEcCtD
Silodosin—Shock—Prednisone—chronic obstructive pulmonary disease	0.000566	0.00181	CcSEcCtD
Silodosin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000564	0.0018	CcSEcCtD
Silodosin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000562	0.00179	CcSEcCtD
Silodosin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000559	0.00179	CcSEcCtD
Silodosin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000524	0.00167	CcSEcCtD
Silodosin—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00052	0.00166	CcSEcCtD
Silodosin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000499	0.0016	CcSEcCtD
Silodosin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000499	0.00159	CcSEcCtD
Silodosin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000496	0.00158	CcSEcCtD
Silodosin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00047	0.0015	CcSEcCtD
Silodosin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00047	0.0015	CcSEcCtD
Silodosin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000457	0.00146	CcSEcCtD
Silodosin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000455	0.00145	CcSEcCtD
Silodosin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000413	0.00132	CcSEcCtD
Silodosin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000407	0.0013	CcSEcCtD
Silodosin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000394	0.00126	CcSEcCtD
Silodosin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00038	0.00122	CcSEcCtD
Silodosin—UGT2B7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000367	0.00235	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000364	0.00233	CbGpPWpGaD
Silodosin—Rash—Prednisone—chronic obstructive pulmonary disease	0.000363	0.00116	CcSEcCtD
Silodosin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000362	0.00116	CcSEcCtD
Silodosin—Headache—Prednisone—chronic obstructive pulmonary disease	0.00036	0.00115	CcSEcCtD
Silodosin—ADRA1D—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000358	0.00229	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000358	0.00229	CbGpPWpGaD
Silodosin—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.000354	0.00227	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000351	0.00225	CbGpPWpGaD
Silodosin—ABCB4—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000345	0.0022	CbGpPWpGaD
Silodosin—ADRA1B—LPA receptor mediated events—MMP9—chronic obstructive pulmonary disease	0.000343	0.00219	CbGpPWpGaD
Silodosin—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000342	0.00219	CbGpPWpGaD
Silodosin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000342	0.00109	CcSEcCtD
Silodosin—ABCB4—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000338	0.00216	CbGpPWpGaD
Silodosin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000335	0.00214	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000334	0.00214	CbGpPWpGaD
Silodosin—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00033	0.00211	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000322	0.00206	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.00032	0.00205	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000319	0.00204	CbGpPWpGaD
Silodosin—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000318	0.00203	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.000313	0.002	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000312	0.00199	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000311	0.00199	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00031	0.00198	CbGpPWpGaD
Silodosin—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000301	0.00192	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000297	0.0019	CbGpPWpGaD
Silodosin—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000296	0.00189	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.00028	0.00179	CbGpPWpGaD
Silodosin—ADRA1B—LPA receptor mediated events—EGFR—chronic obstructive pulmonary disease	0.000277	0.00177	CbGpPWpGaD
Silodosin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000271	0.00173	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000268	0.00171	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000266	0.0017	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000266	0.0017	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000264	0.00169	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000264	0.00169	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.00026	0.00166	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000259	0.00166	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000257	0.00164	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000256	0.00163	CbGpPWpGaD
Silodosin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000249	0.00159	CbGpPWpGaD
Silodosin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000243	0.00155	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000243	0.00155	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000242	0.00155	CbGpPWpGaD
Silodosin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00024	0.00153	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000238	0.00152	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000238	0.00152	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000237	0.00152	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—GC—chronic obstructive pulmonary disease	0.000236	0.00151	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000236	0.00151	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000233	0.00149	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.000231	0.00148	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000228	0.00146	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000226	0.00144	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000226	0.00144	CbGpPWpGaD
Silodosin—UGT2B7—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000224	0.00143	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00022	0.00141	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00022	0.0014	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000219	0.0014	CbGpPWpGaD
Silodosin—ADRA1B—AMPK Signaling—TP53—chronic obstructive pulmonary disease	0.000219	0.0014	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000208	0.00133	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000207	0.00132	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000205	0.00131	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000202	0.00129	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000201	0.00129	CbGpPWpGaD
Silodosin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000197	0.00126	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000197	0.00126	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000196	0.00125	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000195	0.00124	CbGpPWpGaD
Silodosin—ADRA1A—AMPK Signaling—TP53—chronic obstructive pulmonary disease	0.000195	0.00124	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000188	0.0012	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	0.000183	0.00117	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000182	0.00116	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000181	0.00115	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000179	0.00114	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	0.000175	0.00112	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000175	0.00112	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000173	0.00111	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000172	0.0011	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000171	0.0011	CbGpPWpGaD
Silodosin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000171	0.0011	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.00017	0.00109	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000168	0.00107	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000167	0.00106	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000165	0.00106	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.00016	0.00102	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000158	0.00101	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—ALB—chronic obstructive pulmonary disease	0.000154	0.000982	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000153	0.000978	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000151	0.000967	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000151	0.000966	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.00015	0.000958	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000149	0.000953	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	0.000148	0.000949	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000147	0.000939	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000144	0.000921	CbGpPWpGaD
Silodosin—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000142	0.000909	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000137	0.000877	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000137	0.000874	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	0.000136	0.000871	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000134	0.000858	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000133	0.000851	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000133	0.000848	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000131	0.000838	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000129	0.000826	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000128	0.00082	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000128	0.000816	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	0.000127	0.000813	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000127	0.000809	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000122	0.000779	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000121	0.000775	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00012	0.000768	CbGpPWpGaD
Silodosin—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000119	0.000758	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000118	0.000754	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000117	0.000745	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000117	0.000745	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000114	0.00073	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000111	0.000706	CbGpPWpGaD
Silodosin—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000109	0.000696	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000107	0.000686	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000106	0.00068	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000105	0.000671	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.000669	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000104	0.000663	CbGpPWpGaD
Silodosin—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.00066	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000102	0.000653	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000101	0.000643	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	9.77e-05	0.000624	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	9.77e-05	0.000624	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	9.73e-05	0.000622	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	9.48e-05	0.000606	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	9.45e-05	0.000604	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	9.33e-05	0.000596	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	9.27e-05	0.000593	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.06e-05	0.000579	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.95e-05	0.000572	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	8.94e-05	0.000571	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	8.93e-05	0.000571	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.83e-05	0.000564	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	8.81e-05	0.000563	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	8.61e-05	0.00055	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	8.48e-05	0.000542	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	8.43e-05	0.000539	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	8.42e-05	0.000538	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.23e-05	0.000526	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.19e-05	0.000524	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	8.11e-05	0.000518	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	8.11e-05	0.000518	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	8.11e-05	0.000518	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	8.07e-05	0.000516	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.8e-05	0.000498	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	7.7e-05	0.000492	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	7.65e-05	0.000489	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	7.53e-05	0.000481	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	7.41e-05	0.000474	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	7.32e-05	0.000468	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	7.2e-05	0.00046	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	7.2e-05	0.00046	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	7.17e-05	0.000458	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.14e-05	0.000457	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.03e-05	0.000449	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	6.84e-05	0.000437	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	6.73e-05	0.00043	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	6.72e-05	0.00043	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.64e-05	0.000424	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	6.59e-05	0.000421	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	6.59e-05	0.000421	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	6.28e-05	0.000401	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.13e-05	0.000392	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	5.98e-05	0.000382	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.93e-05	0.000379	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.58e-05	0.000357	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	5.53e-05	0.000354	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.52e-05	0.000353	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.51e-05	0.000352	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.48e-05	0.00035	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	5.43e-05	0.000347	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—ALB—chronic obstructive pulmonary disease	5.3e-05	0.000339	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.27e-05	0.000337	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.09e-05	0.000325	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—NOS3—chronic obstructive pulmonary disease	5.07e-05	0.000324	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.05e-05	0.000323	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.01e-05	0.00032	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.98e-05	0.000318	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.9e-05	0.000313	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.82e-05	0.000308	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.79e-05	0.000306	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.76e-05	0.000304	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.58e-05	0.000293	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.55e-05	0.000291	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.52e-05	0.000289	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.45e-05	0.000285	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.34e-05	0.000278	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.22e-05	0.00027	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.16e-05	0.000266	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.13e-05	0.000264	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.07e-05	0.00026	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.04e-05	0.000258	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4e-05	0.000256	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.98e-05	0.000254	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.7e-05	0.000236	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.69e-05	0.000236	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.67e-05	0.000235	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.66e-05	0.000234	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.53e-05	0.000226	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.5e-05	0.000223	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.34e-05	0.000213	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.34e-05	0.000213	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.29e-05	0.00021	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.28e-05	0.00021	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.07e-05	0.000196	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.04e-05	0.000194	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.97e-05	0.00019	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.96e-05	0.000189	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.93e-05	0.000187	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.91e-05	0.000186	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.9e-05	0.000185	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.82e-05	0.00018	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.77e-05	0.000177	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.7e-05	0.000173	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.68e-05	0.000171	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.68e-05	0.000171	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.58e-05	0.000165	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.47e-05	0.000158	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.46e-05	0.000157	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.46e-05	0.000157	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.4e-05	0.000154	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.34e-05	0.000149	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.22e-05	0.000142	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.21e-05	0.000141	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.18e-05	0.000139	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.16e-05	0.000138	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.08e-05	0.000133	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.06e-05	0.000131	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.03e-05	0.00013	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2e-05	0.000128	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.98e-05	0.000126	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.97e-05	0.000126	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.89e-05	0.000121	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.89e-05	0.000121	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.83e-05	0.000117	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.82e-05	0.000116	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.8e-05	0.000115	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.79e-05	0.000114	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.77e-05	0.000113	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.66e-05	0.000106	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.63e-05	0.000104	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.6e-05	0.000102	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.51e-05	9.64e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.38e-05	8.82e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.34e-05	8.56e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.23e-05	7.84e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.22e-05	7.78e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.16e-05	7.44e-05	CbGpPWpGaD
